J&J Picks Up Listerine, Nicorette With $16.6 Bil. Purchase Of Pfizer OTCs
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's successful bid to acquire Pfizer Consumer Healthcare extends the firm's reach in the global OTC market and provides entry into several new product categories